The Cigna Group (CI) FY2024 YTD Q3 P&L / Income Statement

The Cigna Group (CI) FY2024 YTD Q3 P&L / Income Statement

Income statement for 2024-01-01 through 2024-09-30. View: Revenue categories. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

TOTAL REVENUES

181,472,000,000 US dollars

TOTAL BENEFITS AND EXPENSES

174,228,000,000 US dollars

Income from operations

7,244,000,000 US dollars

Other income (expense), net (calculated)

negative 3,984,000,000 US dollars

Income before income taxes

3,260,000,000 US dollars

TOTAL INCOME TAXES

1,018,000,000 US dollars

Net income

2,242,000,000 US dollars

Pharmacy revenues

135,421,000,000 US dollars

Fees and other revenues

10,862,000,000 US dollars

Premiums

34,493,000,000 US dollars

Net investment income

696,000,000 US dollars

Pharmacy and other service costs

133,488,000,000 US dollars

Medical costs and other benefit expenses

28,482,000,000 US dollars

Selling, general and administrative expenses

10,979,000,000 US dollars

Amortization of acquired intangible assets

1,279,000,000 US dollars

Chart connections

• Revenue minus operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Of which attributable to The Cigna Group: $2.01 B; to noncontrolling interests: $232.00 M.